Please provide your email address to receive an email when new articles are posted on . Juvéderm Voluma XC injected into three facial subregions resulted in high responder rates at 6 months, according ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Juvéderm Voluma XC is well-tolerated with ...
The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results